Annual report

Period2021-01-01 → 2021-12-31

Filed2023-03-03

StandardJapan GAAP

ConsolidatedYes

Data checks24 of 24 passed

Amends S100NPBX. Amended by S100QC29 (2023-03-03).

Key figures · 148

Metric	Value	Period	Scope	Source row
Revenue	¥78.6bn	2021-01-01 → 2021-12-31	Cons.	Net sales
Revenue	¥77.7bn	2020-01-01 → 2020-12-31	Cons.	Net sales
Revenue	¥75.4bn	2019-01-01 → 2019-12-31^d	Cons.	Net sales (5-year summary)
Revenue	¥77.2bn	2018-01-01 → 2018-12-31^d	Cons.	Net sales (5-year summary)
Revenue	¥78.7bn	2017-01-01 → 2017-12-31^d	Cons.	Net sales (5-year summary)
Operating income	¥1.2bn	2021-01-01 → 2021-12-31	Cons.	Operating income
Operating income	¥2.2bn	2020-01-01 → 2020-12-31	Cons.	Operating income
Ordinary income	¥1.3bn	2021-01-01 → 2021-12-31	Cons.	Ordinary income
Ordinary income	¥2.2bn	2020-01-01 → 2020-12-31	Cons.	Ordinary income
Ordinary income	¥1.7bn	2019-01-01 → 2019-12-31^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥1.6bn	2018-01-01 → 2018-12-31^d	Cons.	Ordinary income loss (5-year summary)
Ordinary income	¥1.9bn	2017-01-01 → 2017-12-31^d	Cons.	Ordinary income loss (5-year summary)
Profit before tax	¥464m	2021-01-01 → 2021-12-31	Cons.	Income before income taxes
Profit before tax	¥1.8bn	2020-01-01 → 2020-12-31	Cons.	Income before income taxes
Net income (owners)	¥299m	2021-01-01 → 2021-12-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥1.1bn	2020-01-01 → 2020-12-31	Cons.	Profit loss attributable to owners of parent
Net income (owners)	¥1.1bn	2019-01-01 → 2019-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥469m	2018-01-01 → 2018-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income (owners)	¥1.3bn	2017-01-01 → 2017-12-31^d	Cons.	Profit loss attributable to owners of parent (5-year summary)
Net income	¥261m	2021-01-01 → 2021-12-31	Cons.	Profit loss
Net income	¥1.2bn	2020-01-01 → 2020-12-31	Cons.	Profit loss
Total assets	¥52.3bn	at 2021-12-31	Cons.	Assets
Total assets	¥51.7bn	at 2020-12-31	Cons.	Assets
Total assets	¥52.6bn	at 2019-12-31^d	Cons.	Total assets (5-year summary)
Total assets	¥53.3bn	at 2018-12-31^d	Cons.	Total assets (5-year summary)
Total assets	¥54.5bn	at 2017-12-31^d	Cons.	Total assets (5-year summary)
Total liabilities	¥30.2bn	at 2021-12-31	Cons.	Liabilities
Total liabilities	¥29.6bn	at 2020-12-31	Cons.	Liabilities
Net assets / equity	¥22.0bn	at 2021-12-31	Cons.	Net assets
Net assets / equity	¥22.1bn	at 2020-12-31	Cons.	Net assets
Net assets / equity	¥21.8bn	at 2019-12-31^d	Cons.	Net assets
Net assets / equity	¥21.2bn	at 2018-12-31^d	Cons.	Net assets (5-year summary)
Net assets / equity	¥21.3bn	at 2017-12-31^d	Cons.	Net assets (5-year summary)
Cash and deposits	¥990m	at 2021-12-31	Cons.	Cash and deposits
Cash and deposits	¥915m	at 2020-12-31	Cons.	Cash and deposits
Cash & equivalents	¥986m	at 2021-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥910m	at 2020-12-31	Cons.	Cash and cash equivalents
Cash & equivalents	¥1.2bn	at 2019-12-31^d	Cons.	Cash and cash equivalents
Cash & equivalents	¥1.2bn	at 2018-12-31^d	Cons.	Cash and cash equivalents (5-year summary)
Cash & equivalents	¥1.3bn	at 2017-12-31^d	Cons.	Cash and cash equivalents (5-year summary)
Operating cash flow	¥1.6bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥4.8bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in operating activities
Operating cash flow	¥3.9bn	2019-01-01 → 2019-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥3.7bn	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Operating cash flow	¥3.1bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in operating activities (5-year summary)
Investing cash flow	−¥2.9bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥3.5bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in investment activities
Investing cash flow	−¥2.3bn	2019-01-01 → 2019-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥3.0bn	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Investing cash flow	−¥2.0bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in investing activities (5-year summary)
Financing cash flow	¥1.4bn	2021-01-01 → 2021-12-31	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥1.5bn	2020-01-01 → 2020-12-31	Cons.	Net cash provided by used in financing activities
Financing cash flow	−¥1.7bn	2019-01-01 → 2019-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥828m	2018-01-01 → 2018-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
Financing cash flow	−¥1.7bn	2017-01-01 → 2017-12-31^d	Cons.	Net cash provided by used in financing activities (5-year summary)
EPS (basic)	¥5.03	2021-01-01 → 2021-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥19.26	2020-01-01 → 2020-12-31	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥18.28	2019-01-01 → 2019-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥7.77	2018-01-01 → 2018-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
EPS (basic)	¥20.82	2017-01-01 → 2017-12-31^d	Cons.	Basic earnings loss per share (5-year summary)
Net assets per share	¥336.73	at 2021-12-31	Cons.	Net assets per share (5-year summary)
Net assets per share	¥336.41	at 2020-12-31	Cons.	Net assets per share (5-year summary)
Net assets per share	¥328.38	at 2019-12-31^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥315.65	at 2018-12-31^d	Cons.	Net assets per share (5-year summary)
Net assets per share	¥317.39	at 2017-12-31^d	Cons.	Net assets per share (5-year summary)
Equity ratio	38.3%	at 2021-12-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	38.7%	at 2020-12-31	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	37.6%	at 2019-12-31^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	35.8%	at 2018-12-31^d	Cons.	Equity to asset ratio (5-year summary)
Equity ratio	35.2%	at 2017-12-31^d	Cons.	Equity to asset ratio (5-year summary)
ROE	1.5%	2021-01-01 → 2021-12-31	Cons.	Rate of return on equity (5-year summary)
ROE	5.8%	2020-01-01 → 2020-12-31	Cons.	Rate of return on equity (5-year summary)
ROE	5.7%	2019-01-01 → 2019-12-31^d	Cons.	Rate of return on equity (5-year summary)
ROE	2.5%	2018-01-01 → 2018-12-31^d	Cons.	Rate of return on equity (5-year summary)
ROE	6.7%	2017-01-01 → 2017-12-31^d	Cons.	Rate of return on equity (5-year summary)
Employees	879	at 2021-12-31	Cons.	Number of employees
Employees	908	at 2020-12-31	Cons.	Number of employees
Employees	906	at 2019-12-31^d	Cons.	Number of employees
Employees	947	at 2018-12-31^d	Cons.	Number of employees
Employees	955	at 2017-12-31^d	Cons.	Number of employees
Revenue	¥2.5bn	2021-01-01 → 2021-12-31	Standalone	Net sales
Revenue	¥2.5bn	2020-01-01 → 2020-12-31	Standalone	Net sales
Revenue	¥2.5bn	2019-01-01 → 2019-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.6bn	2018-01-01 → 2018-12-31^d	Standalone	Net sales (5-year summary)
Revenue	¥2.5bn	2017-01-01 → 2017-12-31^d	Standalone	Net sales (5-year summary)
Operating income	¥1.2bn	2021-01-01 → 2021-12-31	Standalone	Operating income
Operating income	¥1.1bn	2020-01-01 → 2020-12-31	Standalone	Operating income
Ordinary income	¥1.2bn	2021-01-01 → 2021-12-31	Standalone	Ordinary income
Ordinary income	¥1.0bn	2020-01-01 → 2020-12-31	Standalone	Ordinary income
Ordinary income	¥853m	2019-01-01 → 2019-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥625m	2018-01-01 → 2018-12-31^d	Standalone	Ordinary income loss (5-year summary)
Ordinary income	¥166m	2017-01-01 → 2017-12-31^d	Standalone	Ordinary income loss (5-year summary)
Profit before tax	¥983m	2021-01-01 → 2021-12-31	Standalone	Income before income taxes
Profit before tax	¥717m	2020-01-01 → 2020-12-31	Standalone	Income before income taxes
Net income	¥839m	2021-01-01 → 2021-12-31	Standalone	Profit loss
Net income	¥716m	2020-01-01 → 2020-12-31	Standalone	Profit loss
Net income	¥979m	2019-01-01 → 2019-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥87m	2018-01-01 → 2018-12-31^d	Standalone	Net income loss (5-year summary)
Net income	¥85m	2017-01-01 → 2017-12-31^d	Standalone	Net income loss (5-year summary)
Total assets	¥34.8bn	at 2021-12-31	Standalone	Assets
Total assets	¥33.4bn	at 2020-12-31	Standalone	Assets
Total assets	¥33.2bn	at 2019-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥33.3bn	at 2018-12-31^d	Standalone	Total assets (5-year summary)
Total assets	¥33.9bn	at 2017-12-31^d	Standalone	Total assets (5-year summary)
Total liabilities	¥18.1bn	at 2021-12-31	Standalone	Liabilities
Total liabilities	¥17.3bn	at 2020-12-31	Standalone	Liabilities
Net assets / equity	¥16.6bn	at 2021-12-31	Standalone	Net assets
Net assets / equity	¥16.2bn	at 2020-12-31	Standalone	Net assets
Net assets / equity	¥16.3bn	at 2019-12-31^d	Standalone	Net assets
Net assets / equity	¥15.9bn	at 2018-12-31^d	Standalone	Net assets (5-year summary)
Net assets / equity	¥16.3bn	at 2017-12-31^d	Standalone	Net assets (5-year summary)
Cash and deposits	¥140m	at 2021-12-31	Standalone	Cash and deposits
Cash and deposits	¥120m	at 2020-12-31	Standalone	Cash and deposits
EPS (basic)	¥14.13	2021-01-01 → 2021-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥12.03	2020-01-01 → 2020-12-31	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥16.21	2019-01-01 → 2019-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥1.45	2018-01-01 → 2018-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
EPS (basic)	¥1.42	2017-01-01 → 2017-12-31^d	Standalone	Basic earnings loss per share (5-year summary)
Dividend per share	¥7	2021-01-01 → 2021-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2020-01-01 → 2020-12-31	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2019-01-01 → 2019-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2018-01-01 → 2018-12-31^d	Standalone	Dividend paid per share (5-year summary)
Dividend per share	¥7	2017-01-01 → 2017-12-31^d	Standalone	Dividend paid per share (5-year summary)
Net assets per share	¥279.87	at 2021-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥272.03	at 2020-12-31	Standalone	Net assets per share (5-year summary)
Net assets per share	¥270.67	at 2019-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥262.74	at 2018-12-31^d	Standalone	Net assets per share (5-year summary)
Net assets per share	¥270.12	at 2017-12-31^d	Standalone	Net assets per share (5-year summary)
Equity ratio	47.8%	at 2021-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	48.4%	at 2020-12-31	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	49.1%	at 2019-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	47.7%	at 2018-12-31^d	Standalone	Equity to asset ratio (5-year summary)
Equity ratio	48.1%	at 2017-12-31^d	Standalone	Equity to asset ratio (5-year summary)
ROE	5.1%	2021-01-01 → 2021-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	4.4%	2020-01-01 → 2020-12-31	Standalone	Rate of return on equity (5-year summary)
ROE	6.1%	2019-01-01 → 2019-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	0.5%	2018-01-01 → 2018-12-31^d	Standalone	Rate of return on equity (5-year summary)
ROE	0.5%	2017-01-01 → 2017-12-31^d	Standalone	Rate of return on equity (5-year summary)
Shares issued	65,586,196	at 2021-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2020-12-31	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2019-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2018-12-31^d	Standalone	Total number of issued shares (5-year summary)
Shares issued	65,586,196	at 2017-12-31^d	Standalone	Total number of issued shares (5-year summary)
Employees	37	at 2021-12-31	Standalone	Number of employees
Employees	44	at 2020-12-31	Standalone	Number of employees
Employees	46	at 2019-12-31^d	Standalone	Number of employees
Employees	51	at 2018-12-31^d	Standalone	Number of employees
Employees	49	at 2017-12-31^d	Standalone	Number of employees

Periods use the dates stated in the filing. ^d = earlier-year period dated by calendar; ^v = that date confirmed by the company's own earlier filing.

Segments · 88

Segment	Item	Period	Value
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	depreciation	2021-01-01 → 2021-12-31	¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2021-01-01 → 2021-12-31	¥71m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2021-01-01 → 2021-12-31	¥71m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment assets	at 2021-12-31	¥47m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2021-01-01 → 2021-12-31	¥14m
Reconciling Itemsreconciling	capex	2021-01-01 → 2021-12-31	¥1.3bn
Reconciling Itemsreconciling	depreciation	2021-01-01 → 2021-12-31	¥148m
Reconciling Itemsreconciling	revenue	2021-01-01 → 2021-12-31	−¥12m
Reconciling Itemsreconciling	revenue intersegment	2021-01-01 → 2021-12-31	−¥12m
Reconciling Itemsreconciling	segment assets	at 2021-12-31	¥4.5bn
Enzymatic Medicinereportable segment	capex	2021-01-01 → 2021-12-31	¥85m
Enzymatic Medicinereportable segment	depreciation	2021-01-01 → 2021-12-31	¥243m
Enzymatic Medicinereportable segment	employees	at 2021-12-31	113 pure
Enzymatic Medicinereportable segment	revenue	2021-01-01 → 2021-12-31	¥3.3bn
Enzymatic Medicinereportable segment	revenue external	2021-01-01 → 2021-12-31	¥3.3bn
Enzymatic Medicinereportable segment	segment assets	at 2021-12-31	¥3.5bn
Enzymatic Medicinereportable segment	segment profit	2021-01-01 → 2021-12-31	¥566m
Liquorreportable segment	capex	2021-01-01 → 2021-12-31	¥593m
Liquorreportable segment	depreciation	2021-01-01 → 2021-12-31	¥1.2bn
Liquorreportable segment	employees	at 2021-12-31	699 pure
Liquorreportable segment	revenue	2021-01-01 → 2021-12-31	¥71.1bn
Liquorreportable segment	revenue external	2021-01-01 → 2021-12-31	¥71.1bn
Liquorreportable segment	revenue intersegment	2021-01-01 → 2021-12-31	¥12m
Liquorreportable segment	segment assets	at 2021-12-31	¥39.0bn
Liquorreportable segment	segment profit	2021-01-01 → 2021-12-31	¥499m
Real Estatereportable segment	capex	2021-01-01 → 2021-12-31	¥312m
Real Estatereportable segment	depreciation	2021-01-01 → 2021-12-31	¥46m
Real Estatereportable segment	employees	at 2021-12-31	1 pure
Real Estatereportable segment	revenue	2021-01-01 → 2021-12-31	¥360m
Real Estatereportable segment	revenue external	2021-01-01 → 2021-12-31	¥360m
Real Estatereportable segment	segment assets	at 2021-12-31	¥2.5bn
Real Estatereportable segment	segment profit	2021-01-01 → 2021-12-31	¥185m
Starch For Processingreportable segment	capex	2021-01-01 → 2021-12-31	¥20m
Starch For Processingreportable segment	depreciation	2021-01-01 → 2021-12-31	¥56m
Starch For Processingreportable segment	employees	at 2021-12-31	29 pure
Starch For Processingreportable segment	revenue	2021-01-01 → 2021-12-31	¥3.8bn
Starch For Processingreportable segment	revenue external	2021-01-01 → 2021-12-31	¥3.8bn
Starch For Processingreportable segment	segment assets	at 2021-12-31	¥2.7bn
Starch For Processingreportable segment	segment profit	2021-01-01 → 2021-12-31	−¥59m
—segment total	capex	2021-01-01 → 2021-12-31	¥1.0bn
—segment total	depreciation	2021-01-01 → 2021-12-31	¥1.6bn
—segment total	revenue	2021-01-01 → 2021-12-31	¥78.6bn
—segment total	revenue external	2021-01-01 → 2021-12-31	¥78.5bn
—segment total	revenue intersegment	2021-01-01 → 2021-12-31	¥12m
—segment total	segment assets	at 2021-12-31	¥47.7bn
—segment total	segment profit	2021-01-01 → 2021-12-31	¥1.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	depreciation	2020-01-01 → 2020-12-31	¥0
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue	2020-01-01 → 2020-12-31	¥72m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	revenue external	2020-01-01 → 2020-12-31	¥72m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment assets	at 2020-12-31	¥58m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments	segment profit	2020-01-01 → 2020-12-31	¥13m
Reconciling Itemsreconciling	capex	2020-01-01 → 2020-12-31	¥558m
Reconciling Itemsreconciling	depreciation	2020-01-01 → 2020-12-31	¥220m
Reconciling Itemsreconciling	revenue	2020-01-01 → 2020-12-31	−¥9m
Reconciling Itemsreconciling	revenue intersegment	2020-01-01 → 2020-12-31	−¥9m
Reconciling Itemsreconciling	segment assets	at 2020-12-31	¥3.7bn
Enzymatic Medicinereportable segment	capex	2020-01-01 → 2020-12-31	¥141m
Enzymatic Medicinereportable segment	depreciation	2020-01-01 → 2020-12-31	¥246m
Enzymatic Medicinereportable segment	revenue	2020-01-01 → 2020-12-31	¥3.3bn
Enzymatic Medicinereportable segment	revenue external	2020-01-01 → 2020-12-31	¥3.3bn
Enzymatic Medicinereportable segment	segment assets	at 2020-12-31	¥3.8bn
Enzymatic Medicinereportable segment	segment profit	2020-01-01 → 2020-12-31	¥591m
Liquorreportable segment	capex	2020-01-01 → 2020-12-31	¥937m
Liquorreportable segment	depreciation	2020-01-01 → 2020-12-31	¥1.2bn
Liquorreportable segment	revenue	2020-01-01 → 2020-12-31	¥70.4bn
Liquorreportable segment	revenue external	2020-01-01 → 2020-12-31	¥70.4bn
Liquorreportable segment	revenue intersegment	2020-01-01 → 2020-12-31	¥9m
Liquorreportable segment	segment assets	at 2020-12-31	¥40.2bn
Liquorreportable segment	segment profit	2020-01-01 → 2020-12-31	¥1.3bn
Real Estatereportable segment	capex	2020-01-01 → 2020-12-31	¥8m
Real Estatereportable segment	depreciation	2020-01-01 → 2020-12-31	¥34m
Real Estatereportable segment	revenue	2020-01-01 → 2020-12-31	¥351m
Real Estatereportable segment	revenue external	2020-01-01 → 2020-12-31	¥351m
Real Estatereportable segment	segment assets	at 2020-12-31	¥1.7bn
Real Estatereportable segment	segment profit	2020-01-01 → 2020-12-31	¥186m
Starch For Processingreportable segment	capex	2020-01-01 → 2020-12-31	¥61m
Starch For Processingreportable segment	depreciation	2020-01-01 → 2020-12-31	¥62m
Starch For Processingreportable segment	revenue	2020-01-01 → 2020-12-31	¥3.6bn
Starch For Processingreportable segment	revenue external	2020-01-01 → 2020-12-31	¥3.6bn
Starch For Processingreportable segment	segment assets	at 2020-12-31	¥2.2bn
Starch For Processingreportable segment	segment profit	2020-01-01 → 2020-12-31	¥148m
—segment total	capex	2020-01-01 → 2020-12-31	¥1.1bn
—segment total	depreciation	2020-01-01 → 2020-12-31	¥1.5bn
—segment total	revenue	2020-01-01 → 2020-12-31	¥77.6bn
—segment total	revenue external	2020-01-01 → 2020-12-31	¥77.6bn
—segment total	revenue intersegment	2020-01-01 → 2020-12-31	¥9m
—segment total	segment assets	at 2020-12-31	¥47.9bn
—segment total	segment profit	2020-01-01 → 2020-12-31	¥2.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,622

Item	Context	Value
Dividend paid per share (5-year summary)	Prior2YearDuration_NonConsolidatedMember	7.00
Dividend paid per share (5-year summary)	Prior1YearDuration_NonConsolidatedMember	7.00
Dividend paid per share (5-year summary)	CurrentYearDuration_NonConsolidatedMember	7.00
Basic earnings loss per share (5-year summary)	Prior4YearDuration_NonConsolidatedMember	1.42
Basic earnings loss per share (5-year summary)	Prior3YearDuration_NonConsolidatedMember	1.45
Basic earnings loss per share (5-year summary)	Prior2YearDuration_NonConsolidatedMember	16.21
Basic earnings loss per share (5-year summary)	Prior1YearDuration_NonConsolidatedMember	12.03
Basic earnings loss per share (5-year summary)	CurrentYearDuration_NonConsolidatedMember	14.13
Diluted earnings per share (5-year summary)	Prior4YearDuration_NonConsolidatedMember	－
Diluted earnings per share (5-year summary)	Prior3YearDuration_NonConsolidatedMember	－
Diluted earnings per share (5-year summary)	Prior2YearDuration_NonConsolidatedMember	－
Diluted earnings per share (5-year summary)	Prior1YearDuration_NonConsolidatedMember	－
Diluted earnings per share (5-year summary)	CurrentYearDuration_NonConsolidatedMember	－
Equity to asset ratio (5-year summary)	Prior4YearInstant_NonConsolidatedMember	0.481
Equity to asset ratio (5-year summary)	Prior3YearInstant_NonConsolidatedMember	0.477
Equity to asset ratio (5-year summary)	Prior2YearInstant_NonConsolidatedMember	0.491
Equity to asset ratio (5-year summary)	Prior1YearInstant_NonConsolidatedMember	0.484
Equity to asset ratio (5-year summary)	CurrentYearInstant_NonConsolidatedMember	0.478
Rate of return on equity (5-year summary)	Prior4YearDuration_NonConsolidatedMember	0.0051
Rate of return on equity (5-year summary)	Prior3YearDuration_NonConsolidatedMember	0.0054
Rate of return on equity (5-year summary)	Prior2YearDuration_NonConsolidatedMember	0.0609
Rate of return on equity (5-year summary)	Prior1YearDuration_NonConsolidatedMember	0.0442
Rate of return on equity (5-year summary)	CurrentYearDuration_NonConsolidatedMember	0.0512
Price earnings ratio (5-year summary)	Prior4YearDuration_NonConsolidatedMember	260.6
Price earnings ratio (5-year summary)	Prior3YearDuration_NonConsolidatedMember	239.3
Price earnings ratio (5-year summary)	Prior2YearDuration_NonConsolidatedMember	24.5
Price earnings ratio (5-year summary)	Prior1YearDuration_NonConsolidatedMember	34.1
Price earnings ratio (5-year summary)	CurrentYearDuration_NonConsolidatedMember	25.5
Payout ratio (5-year summary)	Prior4YearDuration_NonConsolidatedMember	4.930
Payout ratio (5-year summary)	Prior3YearDuration_NonConsolidatedMember	4.828
Payout ratio (5-year summary)	Prior2YearDuration_NonConsolidatedMember	0.432
Payout ratio (5-year summary)	Prior1YearDuration_NonConsolidatedMember	0.582
Payout ratio (5-year summary)	CurrentYearDuration_NonConsolidatedMember	0.495
Number of employees	Prior4YearInstant_NonConsolidatedMember	49
Number of employees	Prior3YearInstant_NonConsolidatedMember	51
Number of employees	Prior2YearInstant_NonConsolidatedMember	46
Number of employees	Prior1YearInstant_NonConsolidatedMember	44
Number of employees	CurrentYearInstant_NonConsolidatedMember	37
Average number of temporary workers	Prior4YearInstant_NonConsolidatedMember	9
Average number of temporary workers	Prior3YearInstant_NonConsolidatedMember	7
Average number of temporary workers	Prior2YearInstant_NonConsolidatedMember	9
Average number of temporary workers	Prior1YearInstant_NonConsolidatedMember	8
Average number of temporary workers	CurrentYearInstant_NonConsolidatedMember	8
Total shareholder return	Prior4YearInstant_NonConsolidatedMember	1.456
Total shareholder return	Prior3YearInstant_NonConsolidatedMember	1.394
Total shareholder return	Prior2YearInstant_NonConsolidatedMember	1.614
Total shareholder return	Prior1YearInstant_NonConsolidatedMember	1.691
Total shareholder return	CurrentYearInstant_NonConsolidatedMember	1.525
Total return on share price index	Prior4YearInstant_NonConsolidatedMember	1.222
Total return on share price index	Prior3YearInstant_NonConsolidatedMember	1.027

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed

balance sheet identity	consolidated 2020-12-31	pass
balance sheet identity	consolidated 2021-12-31	pass
balance sheet identity	non_consolidated 2020-12-31	pass
balance sheet identity	non_consolidated 2021-12-31	pass rounding
dei present		pass
period resolution		pass
statement vs summary · net assets	consolidated 2019-12-31	pass
statement vs summary · net assets	consolidated 2020-12-31	pass
statement vs summary · net assets	consolidated 2021-12-31	pass
statement vs summary · net assets	non_consolidated 2019-12-31	pass
statement vs summary · net assets	non_consolidated 2020-12-31	pass
statement vs summary · net assets	non_consolidated 2021-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · net income attributable to parent	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · operating cash flow	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · operating cash flow	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · revenue	consolidated 2020-01-01/2020-12-31	pass
statement vs summary · revenue	consolidated 2021-01-01/2021-12-31	pass
statement vs summary · revenue	non_consolidated 2020-01-01/2020-12-31	pass
statement vs summary · revenue	non_consolidated 2021-01-01/2021-12-31	pass
statement vs summary · total assets	consolidated 2020-12-31	pass
statement vs summary · total assets	consolidated 2021-12-31	pass
statement vs summary · total assets	non_consolidated 2020-12-31	pass
statement vs summary · total assets	non_consolidated 2021-12-31	pass